Ra Pharmaceuticals, Inc.
2 clinical trials · Sponsor
◉ Watch Ra Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis (NCT04115293) | Ra Pharmaceuticals, Inc. | 2019-09-17 |
| Extension Study of RA101495 for Patients With PNH Who Have Completed a Zilucoplan (RA101495) Clinical Study (NCT03225287) | Ra Pharmaceuticals, Inc. | 2017-07-17 |
Track Ra Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.